Neogenomics PE ratio NEO

Share price divided by earnings per share over the last twelve months, since 2013.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 57.6×; Feb 2022
8-year median: 139×
8-year range: 54.1× to 425×
Peer median: 27.9×

Neogenomics has no meaningful PE ratio today: it lost $0.40 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Feb 2022, at 57.6×.

On the days it had one over the last 8 years, its median was 139×, from 54.1× in Feb 2022 to 425× in Apr 2020.

PE ratio over time

median 139.2×

The dashed line is the 8-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2022	57.6×	54.1×	77.9×
2021	94.8×	73.3×	116×
2020	425×	346×	425×
2019	388×	139×	388×
2018	135×	127×	189×
2017	n/m a value too high to mean anything
2016	n/m a value too high to mean anything
2015	496×	194×	496×
2014	208×	60.6×	242×
2013	122×	117×	128×

Against its peers

Companies in Specialty Business Services nearest Neogenomics' size, closest first, today.

Company	PE ratio
NEONeogenomics	n/m
VVXV2X	25.5×
MHMcGraw Hill	29.2×
DFINDonnelley Financial Solutions	38.3×
CRAICRA International	26.6×
ITGartner	20.7×
ULSUL Solutions	29.6×
Peer median	27.9×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Neogenomics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.